Brief: AB Science Reports Operating Loss Of Eur 8.9 Mln As Of 30 June 2023, Decrease Of 7.5% Compared To First Half 2022
29/09/2023 18:53
Sept 29 (Reuters) - Ab Science Sa ABS.PA :
* AB SCIENCE TODAY REPORTS ITS REVENUES FOR THE FIRST HALF
OF 2023
AND PROVIDES AN UPDATE ON ITS ACTIVITIES
* OPERATING LOSS OF EUR 8.9 MILLION AS OF 30 JUNE 2023, A
DECREASE
OF 7.5% COMPARED TO FIRST HALF OF 2022
Source text for Eikon: ID:nGNX8HP65S
Further company coverage: ABS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041